MC2290A1 - Benzoquinazolines pharmaceutiquement actives - Google Patents

Benzoquinazolines pharmaceutiquement actives

Info

Publication number: MC2290A1
Authority: MC; Monaco
Prior art keywords: benzoquinazolines; pharmaceutically active; pharmaceutically; active; active benzoquinazolines
Prior art date: 1990-06-19

Application number

MC91@@D

Other languages

English (en)

Inventor

William Pendergast

Scott Dickerson

Julius Johnson

Robert Ferone

Original Assignee

Wellcome Found

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-06-19

Filing date

1991-06-18

Publication date

1993-07-14

1991-06-18 Application filed by Wellcome Found filed Critical Wellcome Found

1993-07-14 Publication of MC2290A1 publication Critical patent/MC2290A1/fr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

MC91@@D 1990-06-19 1991-06-18 Benzoquinazolines pharmaceutiquement actives MC2290A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB909013615A GB9013615D0 (en)	1990-06-19	1990-06-19	Pharmaceutical compounds
PCT/GB1991/000977 WO1991019700A1 (fr)	1990-06-19	1991-06-18	Composes de benzoquinazoline pharmaceutiquement actifs

Publications (1)

Publication Number	Publication Date
MC2290A1 true MC2290A1 (fr)	1993-07-14

Family

ID=10677828

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MC91@@D MC2290A1 (fr)	1990-06-19	1991-06-18	Benzoquinazolines pharmaceutiquement actives

Country Status (26)

Country	Link
US (4)	US6090941A (fr)
EP (2)	EP0535034B1 (fr)
JP (1)	JP2966929B2 (fr)
KR (1)	KR0183042B1 (fr)
CN (1)	CN1049215C (fr)
AP (1)	AP218A (fr)
AT (2)	ATE222243T1 (fr)
AU (1)	AU639815B2 (fr)
CA (1)	CA2085589C (fr)
CS (1)	CS186391A3 (fr)
DE (2)	DE69133088T2 (fr)
DK (2)	DK1199307T3 (fr)
ES (2)	ES2178632T3 (fr)
FI (1)	FI925778A0 (fr)
GB (1)	GB9013615D0 (fr)
HU (2)	HUT62273A (fr)
IE (1)	IE912073A1 (fr)
IL (1)	IL98542A (fr)
MC (1)	MC2290A1 (fr)
MY (1)	MY107001A (fr)
NO (1)	NO924929D0 (fr)
NZ (1)	NZ238582A (fr)
PL (1)	PL169927B1 (fr)
PT (1)	PT98021B (fr)
WO (1)	WO1991019700A1 (fr)
ZA (1)	ZA914676B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9013615D0 (en) *	1990-06-19	1990-08-08	Wellcome Found	Pharmaceutical compounds
US6762188B1 (en)	1990-06-19	2004-07-13	Smithkline Beecham Corporation	Pharmaceutically active benzoquinazoline compounds
GB9223352D0 (en) *	1992-11-06	1992-12-23	Ici Plc	Tricyclic compounds
GB9226842D0 (en)	1992-12-23	1993-02-17	Wellcome Found	Pharmaceutical compounds
GB9408936D0 (en) *	1994-05-05	1994-06-22	Cancer Res Inst	Anti-cancer compounds
AU3883600A (en)	1999-03-16	2000-10-04	Regents Of The University Of California, The	Glycosylated polyamines
US6531454B1 (en)	1999-03-16	2003-03-11	The Regents Of The University Of California	Glycosylated polyamines and methods of use therefor
NZ522842A (en) *	2000-06-09	2004-11-26	Osi Pharm Inc	Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
EP1432711A1 (fr) *	2001-09-26	2004-06-30	Bayer Corporation	Derives de 1,6-naphthyridine et leur utilisation dans le traitement du diabete et de troubles associes
CN100434425C (zh) *	2005-03-09	2008-11-19	首都师范大学	4-喹唑啉酮衍生物及其在抗肿瘤药物中的应用
EP1754484A1 (fr) *	2005-08-17	2007-02-21	Dan Stoicescu	Dérives de pyrimidine condenses comme inhibiteurs d`enzymes dependant d`acid folique
AU2006322254B2 (en)	2005-12-05	2012-08-02	Nitto Denko Corporation	Polyglutamate-amino acid conjugates and methods
GB0525069D0 (en) *	2005-12-08	2006-01-18	Novartis Ag	Organic compounds
KR101129868B1 (ko)	2006-10-04	2012-04-12	화이자 프로덕츠 인코포레이티드	칼슘 수용체 길항제로서의 피리도［4,3-ｄ］피리미딘-4(3Ｈ)-온 유도체
EP1958632A1 (fr)	2007-02-14	2008-08-20	Dan Stoicescu	Utilisation de dérivés de la pyrimidine condensés pour le traitement de maladies inflammatoires et autoimmunes
EP2155254B1 (fr) *	2007-05-09	2012-11-28	Nitto Denko Corporation	Polymères conjugués avec des médicaments à base de platine
CN101707869A (zh) *	2007-05-09	2010-05-12	日东电工株式会社	具有多种药物的聚谷氨酸盐结合物和聚谷氨酸盐-氨基酸结合物
ES2430380T3 (es)	2007-05-09	2013-11-20	Nitto Denko Corporation	Composiciones que incluyen un compuesto hidrófobo y un conjugado de poliaminoácido
US8146622B2 (en)	2007-08-20	2012-04-03	Ford Global Technologies, Llc	Switch and hose-valve connection arrangement for vehicle temporary mobility kit
US8517760B2 (en)	2007-08-20	2013-08-27	Ford Global Technologies, Llc	Cord wrap and power plug receptacle arrangement for inflator
US8501242B2 (en)	2009-05-29	2013-08-06	University Of Florida Research Foundation	Methods and compositions for treating neoplasia
CN101580501B (zh) *	2009-06-01	2011-03-09	南京卡文迪许生物工程技术有限公司	3-(取代二氢异吲哚酮-2-基)-2,6-哌啶二酮的合成方法及其中间体
WO2011078226A1 (fr) *	2009-12-22	2011-06-30	協和発酵キリン株式会社	Composé tricyclique

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UST862021I4 (en) *	1969-01-27	1969-05-27		Defensive publication
ZA72442B (en) *	1971-02-05	1972-10-25	Apaw Sa	Automatic ice-cream machine
GB2065653B (en) *	1979-12-19	1983-03-09	Nat Res Dev	Anti-cancer quinazoline derivatives
US4814335A (en) *	1982-12-30	1989-03-21	Biomeasure, Incorporated	Antiviral compounds
GB8513754D0 (en) *	1985-05-31	1985-07-03	Jones T R	Anti-cancer quinazoline derivatives
US4603186A (en)	1985-10-21	1986-07-29	The Standard Oil Company	Tetrapolymers containing indene
GB8607683D0 (en) *	1986-03-27	1986-04-30	Ici Plc	Anti-tumor agents
US4818819A (en) *	1986-10-20	1989-04-04	The Trustees Of Princeton University	Process for the preparation of fused pyridine compounds
GB8707053D0 (en) *	1987-03-25	1987-04-29	Ici Plc	Anti-tumour agents
US4857530A (en) *	1987-11-03	1989-08-15	Warner-Lambert Company	Substituted quinazolinones as anticancer agents
US4902624A (en) *	1987-11-23	1990-02-20	Eastman Kodak Company	Temperature cycling cuvette
GB8727737D0 (en) *	1987-11-26	1987-12-31	Ici Plc	Antitumour agents
GB8829296D0 (en) *	1988-12-15	1989-01-25	Ici Plc	Anti-tumour compounds
US5405851A (en) *	1990-06-19	1995-04-11	Burroughs Wellcome Co.	Pharmaceutical compounds
GB9013615D0 (en) *	1990-06-19	1990-08-08	Wellcome Found	Pharmaceutical compounds

1990
- 1990-06-19 GB GB909013615A patent/GB9013615D0/en active Pending
1991
- 1991-06-18 CS CS911863A patent/CS186391A3/cs unknown
- 1991-06-18 EP EP91910823A patent/EP0535034B1/fr not_active Expired - Lifetime
- 1991-06-18 ES ES91910823T patent/ES2178632T3/es not_active Expired - Lifetime
- 1991-06-18 AP APAP/P/1991/000283A patent/AP218A/en active
- 1991-06-18 DE DE69133088T patent/DE69133088T2/de not_active Expired - Fee Related
- 1991-06-18 NZ NZ238582A patent/NZ238582A/en unknown
- 1991-06-18 KR KR1019920703287A patent/KR0183042B1/ko not_active IP Right Cessation
- 1991-06-18 PL PL91297195A patent/PL169927B1/pl unknown
- 1991-06-18 AT AT91910823T patent/ATE222243T1/de not_active IP Right Cessation
- 1991-06-18 AU AU80943/91A patent/AU639815B2/en not_active Ceased
- 1991-06-18 IE IE207391A patent/IE912073A1/en unknown
- 1991-06-18 MC MC91@@D patent/MC2290A1/fr unknown
- 1991-06-18 ES ES02075192T patent/ES2211851T3/es not_active Expired - Lifetime
- 1991-06-18 DE DE69133371T patent/DE69133371T2/de not_active Expired - Fee Related
- 1991-06-18 ZA ZA914676A patent/ZA914676B/xx unknown
- 1991-06-18 EP EP02075192A patent/EP1199307B1/fr not_active Expired - Lifetime
- 1991-06-18 MY MYPI91001094A patent/MY107001A/en unknown
- 1991-06-18 CA CA002085589A patent/CA2085589C/fr not_active Expired - Lifetime
- 1991-06-18 WO PCT/GB1991/000977 patent/WO1991019700A1/fr active IP Right Grant
- 1991-06-18 DK DK02075192T patent/DK1199307T3/da active
- 1991-06-18 HU HU924011A patent/HUT62273A/hu unknown
- 1991-06-18 JP JP3510950A patent/JP2966929B2/ja not_active Expired - Fee Related
- 1991-06-18 AT AT02075192T patent/ATE260262T1/de not_active IP Right Cessation
- 1991-06-18 DK DK91910823T patent/DK0535034T3/da active
- 1991-06-18 PT PT98021A patent/PT98021B/pt not_active IP Right Cessation
- 1991-06-18 IL IL9854291A patent/IL98542A/en not_active IP Right Cessation
- 1991-06-18 CN CN91105021A patent/CN1049215C/zh not_active Expired - Fee Related
1992
- 1992-12-18 NO NO924929A patent/NO924929D0/no unknown
- 1992-12-18 FI FI925778A patent/FI925778A0/fi not_active Application Discontinuation
1993
- 1993-01-13 US US07/956,018 patent/US6090941A/en not_active Expired - Fee Related
1995
- 1995-05-12 HU HU95P/P00133P patent/HU211265A9/hu unknown
- 1995-05-25 US US08/449,959 patent/US5663337A/en not_active Expired - Lifetime
- 1995-05-26 US US08/452,337 patent/US5661155A/en not_active Expired - Lifetime
2000
- 2000-06-06 US US09/588,790 patent/US6306865B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ATE222243T1 (de)	2002-08-15
ES2211851T3 (es)	2004-07-16
CS186391A3 (en)	1992-04-15
CN1049215C (zh)	2000-02-09
NZ238582A (en)	1993-12-23
US5663337A (en)	1997-09-02
KR0183042B1 (ko)	1999-05-01
WO1991019700A1 (fr)	1991-12-26
MY107001A (en)	1995-08-30
IE912073A1 (en)	1992-01-01
DK1199307T3 (da)	2004-06-14
AU8094391A (en)	1992-01-07
DE69133088D1 (de)	2002-09-19
PT98021A (pt)	1992-04-30
HU9204011D0 (en)	1993-03-29
PL169927B1 (pl)	1996-09-30
CA2085589A1 (fr)	1991-12-20
CA2085589C (fr)	2001-12-18
DE69133371T2 (de)	2005-01-27
KR930701415A (ko)	1993-06-11
ZA914676B (en)	1993-02-24
DE69133371D1 (de)	2004-04-01
DE69133088T2 (de)	2003-03-20
HUT62273A (en)	1993-04-28
HU211265A9 (en)	1995-11-28
CN1058208A (zh)	1992-01-29
EP1199307A1 (fr)	2002-04-24
EP0535034A1 (fr)	1993-04-07
AP218A (en)	1992-09-27
EP0535034B1 (fr)	2002-08-14
GB9013615D0 (en)	1990-08-08
DK0535034T3 (da)	2002-12-09
AP9100283A0 (en)	1991-07-31
ATE260262T1 (de)	2004-03-15
NO924929L (no)	1992-12-18
FI925778A (fi)	1992-12-18
IL98542A (en)	1995-05-26
AU639815B2 (en)	1993-08-05
US5661155A (en)	1997-08-26
FI925778A0 (fi)	1992-12-18
US6090941A (en)	2000-07-18
EP1199307B1 (fr)	2004-02-25
JP2966929B2 (ja)	1999-10-25
US6306865B1 (en)	2001-10-23
ES2178632T3 (es)	2003-01-01
NO924929D0 (no)	1992-12-18
JPH05507704A (ja)	1993-11-04
PT98021B (pt)	1998-11-30
IL98542A0 (en)	1992-07-15

Publication	Publication Date	Title
MC2290A1 (fr)	1993-07-14	Benzoquinazolines pharmaceutiquement actives
FI955939A (fi)	1995-12-11	Farmaseuttisesti aktiivisia CNS-yhdisteitä
TR199501137A2 (tr)	1996-06-21	Terapötik olarak aktif bilesenler
MX9102473A (es)	1992-06-01	Agentes farmaceuticos.
NO930543L (no)	1993-08-18	Doseringsform
FI930882A0 (fi)	1993-02-26	Farmaceutiska foereningar
FI910254A0 (fi)	1991-01-17	Oralt aktiva renininhibitorer.
FI931251A (fi)	1993-09-25	Farmaceutiska foereningar
FI933808A (fi)	1993-08-31	Insekticidiskt aktiva peptider
IT1229231B (it)	1991-07-26	Aminoimidazopiridine farmacologicamente attive
DE68908838D1 (de)	1993-10-07	Pharmazeutisch wirksame Dithioketen-Derivaten.
ITMI921865A1 (it)	1994-01-30	Glicerofosfoderivati farmacologicamente attivi
DE69130099D1 (de)	1998-10-08	Antineoplastischer wirkstoff
ITMI910596A0 (it)	1991-03-07	Gliceroderivati farmacologicamente attivi
IT1229230B (it)	1991-07-26	Piperidinilimidazopiridine farmacologicamente attive.
DE59206745D1 (de)	1996-08-14	Aktive Frequenzweiche
SE8902170D0 (sv)	1989-06-16	Therapeutically active compounds
NO950530D0 (no)	1995-02-13	Farmasöytisk aktive diketopiperaziner
NO950529D0 (no)	1995-02-13	Farmasöytisk aktive diketopiperaziner
SE9201338D0 (sv)	1992-04-28	New active compounds
SE9202553D0 (sv)	1992-09-15	New active compounds ii
BR9403411A (pt)	1996-09-03	Cadeira ativa
SE9700660D0 (sv)	1997-02-25	Pharmaceutically active compounds
SE9303970D0 (sv)	1993-11-30	New active compounds
SE9203897D0 (sv)	1992-12-23	New active compounds iii